妈咪爱治疗新生儿黄疸的临床疗效分析

Clinical Efficiency of Medilac-Vita in Children with Neonatal Jaundice

摘要: 目的：观察分析妈咪爱在新生儿黄疸治疗中的临床疗效。方法：112例新生儿黄疸患儿随机分为治疗组和对照组，每组56例。两组都给予常规治疗，治疗组在常规治疗基础上加服妈咪爱，并通过动态检测经皮测胆红素观察其临床疗效。结果：治疗组患儿血清胆红素与对照组比较下降明显(P < 0.01)，且治疗组治疗7天后的有效率及治愈率方面明显优于对照组。结论：妈咪爱治疗新生儿黄疸，可迅速降低血清胆红素的水平，优于常规治疗。

Abstract:  Objective: To observe the clinical efficiency of Medilac-Vita in children with neonatal jaundice. Methods: 112 cases of newborn with neonatal jaundice were randomly divided into treatment group and control group. All were treated with routine therapy. Oral Medilac-Vita was added to the treatment group. Clinical efficiency was observed by detection of transcautaneous bilirubin. Results: The level of transcautaneous bilirubin in treatment group was significantly lower than the control group. After 7 days of treatment, the effective rate and cure rate of the treatment group are obviously better than the control group. Conclusions: Moreover, the effect of Medilac-Vita in treatment of neonatal jaundice is better than routine treatment, it can reduce the serum bilirubin rapidly.